Sodium–Glucose Cotransporter 2 Inhibitors to Decrease the Uric Acid Concentration—A Novel Mechanism of Action

Sodium–glucose cotransporter 2 inhibitors (SGLT2is) are glucose-lowering agents whose positive impact on cardiovascular risk has been described extensively. Not only do they influence lipid profile, blood pressure, atherosclerosis risk, hemoglobin level, and insulin resistance, but they also reduce...

Descripción completa

Detalles Bibliográficos
Autores principales: Kochanowska, Anna, Rusztyn, Przemysław, Szczerkowska, Karolina, Surma, Stanisław, Gąsecka, Aleksandra, Jaguszewski, Miłosz J., Szarpak, Łukasz, Filipiak, Krzysztof J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380892/
https://www.ncbi.nlm.nih.gov/pubmed/37504524
http://dx.doi.org/10.3390/jcdd10070268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380892/
https://www.ncbi.nlm.nih.gov/pubmed/37504524
http://dx.doi.org/10.3390/jcdd10070268

Ejemplares similares